A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy

Published:2023-06 Issue: Volume:358 Page:204-218
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Shen Tianli,Yang Shuanying,Qu Xiaoyan,Chen Zilu,Zeng Lizhong,Sun Xuejun,Lin Yuyao,Luo Meng,Lei Bo,Yue Chenyang,Ma Chunhong,Hu Nan,Wang Wei,Zhang Long

Funder

China Postdoctoral Science Foundation

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Cancer statistics, 2022;Siegel;Ca-Cancer J. Clin.,2022

2. Tumor immunotherapy directed at PD-1;Ribas;New Engl. J. Med.,2012

3. PD-1 blockade in tumors with mismatch-repair deficiency;Le;New Engl. J. Med.,2015

4. CAR T-cell therapy of solid tumors;Yong;Immunol. Cell Biol.,2017

5. Circulating miRNA analysis for cancer diagnostics and therapy;Valihrach;Mol. Asp. Med.,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

2. Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics;ChemMedChem;2024-09-12

3. Membrane-camouflaged biomimetic nanoplatform with arsenic complex for synergistic reinforcement of liver cancer therapy;Nanomedicine;2024-09-04

4. A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem;Advanced Science;2024-08-29

5. Rolling Circle Amplification-Based Self-Assembly to Form a “GPS-Nanoconveyor” for In Vitro Targeted Imaging and Enhanced Gene/Chemo (CRISPR/DOX) Synergistic Therapy;Biomacromolecules;2024-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3